Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.
Ineligible company
The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Faculty and Disclosures
Daniel Buckland, MD, MS, PhD - Nothing to Disclose
Lawrence Carin, PhD - Nothing to Disclose
David Dov, PhD - Nothing to Disclose
Timothy W. Dunn, PhD - Nothing to Disclose
Nita Farahany, PhD, JD - Illumina: Ethics Consulting, Consulting Fee; Helix: Ethics Consulting, Consulting Fee
Teodor Grantcharov, MD, PhD, FACS - SST Inc: Founder, IP & Salary
Daniel Hashimoto, MD, FACS - Johnson & Johnson: Consulting, Consulting Fee, Verily Life Sciences: Consulting; Worrell: Consulting; Olympus Corporation: Sponsored Research Agreement, Research Support; McGraw Hill Education: Textbook Editor, Royalty Agreement
Ricardo Henao, PhD - Nothing to Disclose
Erich S. Huang, MD, PhD – kelaHealth: Stratus Medicine, Founder, Equity; Clinetic: Founder, Equity; Optimize Health: Advisor, Equity; Valo Health: Consulting; Consulting Fee
Eun Sil S. Hwang, MD, FACS - Nothing to Disclose
Allan D. Kirk, MD, PhD, FACS - Clinetic: Board Chair, Stock; CareDX: Consulting, FMV Consulting Fees; Sanofi: Consulting, FMV Consulting Fees; Eurofins: Consulting, FMV Consulting Fees; Vertex: Consulting, FMV Consulting Fees; Novartis: Consulting, FMV Consulting Fees
Carla M. Pugh, MD, PhD, FACS - Medical Teaching Systems: Founder, Personal Financial Investment; 10 Newtons, Inc: Founder, Personal Financial Investment; 10 Newtons Women’s Wellness Foundation: Founder, Personal Financial Investment; Intuitive Surgical Foundation: Consultant, Consultant Fee; PrecisionOS: Consultant, Consultant Fee
Danielle Elliott Range, MD - Nothing to Disclose
Guy Rosman, PhD - Toyota Research Institute: Senior Research Scientist, Salary; Von Bispharma: Senior Research Scientist, Salary; Olympus: Consultant, Consulting Fee
Frank Rudzicz, PhD - Surgical Safety Technologies Inc: Director of AI, Salary
Ajit K. Sachdeva, MD, FACS, FRCSC, FSACME, MAMSE - Nothing to Disclose
Steering Committee
Patrice Gabler Blair, DrPH, MPH – Nothing to Disclose
Allan D. Kirk, MD, PhD, FACS - Clinetic: Board Chair, Stock; CareDX: Consulting, FMV Consulting Fees; Sanofi: Consulting, FMV Consulting Fees; Eurofins: Consulting, FMV Consulting Fees; Vertex: Consulting, FMV Consulting Fees; Novartis: Consulting, FMV Consulting Fees
Ajit K. Sachdeva, MD, FACS, FRCSC, FSACME, MAMSE - Nothing to Disclose
Special Acknowledgement
The ACS Division of Education extends its gratitude and appreciation to the Duke University Department of Surgery and School of Medicine faculty and staff who shared their expertise and worked diligently to complete this program.